e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Tuberculosis and HIV co-infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
HIV-1 infection impairs the bronchoalveolar immune response to mycobacteria
B. Kalsdorf, T. J. Scriba, K. Wood, C. Day, C. Lange, R. Dawson, K. Dheda, W. A. Hanekom, R. J. Wilkinson (Cape Town, South Africa; Borstel, Germany; London, United Kingdom)
Source:
Annual Congress 2009 - Tuberculosis and HIV co-infection
Session:
Tuberculosis and HIV co-infection
Session type:
E-Communication Session
Number:
3312
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Kalsdorf, T. J. Scriba, K. Wood, C. Day, C. Lange, R. Dawson, K. Dheda, W. A. Hanekom, R. J. Wilkinson (Cape Town, South Africa; Borstel, Germany; London, United Kingdom). HIV-1 infection impairs the bronchoalveolar immune response to mycobacteria. Eur Respir J 2009; 34: Suppl. 53, 3312
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
MTB-specific lymphocytes are selectively recruited to the site of infection in active pulmonary tuberculosis
Source: Annual Congress 2007 - Immunology and genetics of tuberculosis
Year: 2007
Mycolic acid from
mycobacterium tuberculosis
suppresses experimental asthma by triggering the local induction of regulatory T cells
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006
Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005
Estimation immune and cytokine status of children infected M.tuberculosis
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008
A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2012; 40: 1450-1457
Year: 2012
Ex vivo virus infection of HDM-sensitized lung tissue proves inadequate anti-viral immune response in small airways
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
In vitro
immune response to
Mycobacterium tuberculosis
antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005
LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
The antimicrobial peptide CRAMP is a regulator of inflammation during pneumonia
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006
IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT)
Source: Eur Respir J 2001; 18: Suppl. 33, 307s
Year: 2001
A novel immune regulatory function of neutrophils in rhinovirus infections
Source: Lung Science Conference 2015
Year: 2015
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection
Source: Eur Respir J 2010; 35: 619-626
Year: 2010
Defective endogenous antiviral mediator production in response to viral infection
Source: International Congress 2015 – Resolving inflammation
Year: 2015
IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
The attenuation of cytokine response might be correlated with gut dysbiosis in nontuberculous mycobacteria lung disease
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019
Impaired Mtb-specific alveolar T-cell responses in HIV+ persons with latent TB infection
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
IL-4 subverts mycobacterial containment in
Mycobacterium tuberculosis
-infected human macrophages
Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept